The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).
Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!
Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.
https://youtu.be/vMIy8xWLOKI?t=3699
Starts at 1 Hour Mark.
INSIDER HOLDINGS
Booya. We’re up 143% With Ardelyx (ARDX) in Three Months – and That Ain’t...
Ardelyx Adds 16% to $3.82 as Wedbush Upgrades After Q4 Earnings.
Ardelyx ( NASDAQ: ARDX ) gained 35%...
Mitesco (MITI) $0.45 to Open its First Medical Clinic.
LIVE QUOTE
Nice chart ahead of its first clinic opening..
By George, they did...
FDA Issues Final ‘Enforcement Discretion’ Guidance on NAC.
NAC Crosses Major Hurdle With FDA. Is Bucillamine Next.
Josh Long | Aug 01, 2022
"Industry, and...
Dyve Biosciences (Private) Receives FDA Clearance to Begin Phase 2 Study of DYV-700 for...
THOUSAND OAKS, Ca.--(BUSINESS WIRE)--Dyve Biosciences, Inc. today announced that it has received clearance from the U.S. Food and Drug Administration to proceed...
Plansource Invites DarioHealth (DRIO) Into 50 Broker Partnership Network, Serving 5 Million Patients.
This looks like a coup for DarioHealth (DRIO), getting it's digital health solutions in front of more than 5 million new potential...
Dalrada Cervical Cancer Testing Kit Study.
KEY TAKEAWAYS
Dalrada Corp (DFCO)
LIVE QUOTE
Revive Therapeutics (RVVTF) Moves a Step Closer to FDA Verdict for Its Novel Covid...
Two Binary Events Directly Ahead.
As in Months Away, not Years. Share Price up 76% During April.
COVID-19 Immunity From mRNA Booster Does Not Last Very Long.
Study finds that the median length for the antibody half-life immune response was 63 days for the primary series, and increased to...